510(k) device
SpydrBlade Flex Instrument (PRD-RG1-001)
Creo Medical, Ltd. · Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS, Class II) · First FDA decision Jun 6, 2025, newest Jun 6, 2025Enlarged prostate (BPH)Pancreatic and bile duct disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "SpydrBlade Flex"
MAUDE reports
0
Brand "SpydrBlade Flex", since 2015
PubMed studies
0
Mentioning "SpydrBlade Flex"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SpydrBlade Flex Instrument (PRD-RG1-001)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K242774 · Decided Jun 6, 2025 · 266 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SpydrBlade Flex", any status and sponsor, newest update first.
Chinese University of Hong KongAcademic, hospital or other
NCT07406945 · 73 participants (planned) · Start Nov 1, 2024 · Primary completion Oct 1, 2026
Device: SpydrBlade Flex · For: Achalasia; EGJ Outflow Obstruction
Sites: Guayaquil, Ecuador; Hong Kong, Hong Kong
- Prospective Study of Using Novel Bipolar Scissors in Colorectal Endoscopic Submucosal DissectionNot yet recruiting
Chinese University of Hong KongAcademic, hospital or other
NCT06715332 · 30 participants (planned) · Start Dec 8, 2024 · Primary completion Dec 31, 2025
Device: Colorectal ESD with SpydrBlade Flex · For: Colon Polyp; Colon Neoplasia
Sites: Hong Kong, Hong Kong
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SpydrBlade Flex", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KNS
10,605 reports: 7,586 malfunction, 2,954 injury, 60 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SpydrBlade Flex"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code KNS.
- Single Use Electrosurgical Knife (KD-612L, KD-612U)Olympus Medical Systems Corporation · 510(k) 2025
- Aqua Medical RF Vapor Ablation SystemAqua Medical, Inc. · 510(k) 2025
- Rezum SystemNxthera, Inc. · 510(k) 2018
- Rezum SystemBoston Scientific · 510(k) 2026
- Single Use Preloaded Sphincterotome V (Distal Wire Guided) (KD-VC600 Series)Olympus Medical Systems Corp. · 510(k) 2025
- Teslatome Bipolar SphincterotomeWilson-Cook Medical, Inc. · 510(k) 2025
- ELRA Electrode (7-2B11SStarmed Co., Ltd. · 510(k) 2023
- SphincterotomeHangzhou AGS MedTech Co., Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.